Please Wait.....
Report
Decentralized Clinical Trials: Global Markets
Market Research Report I 2026-02-18 I 84 Pages I BCC Research
Description
Report Scope
This report analyzes the trends in the global market for decentralized clinical trials. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period of 2025 through 2030. The market is segmented by study design (interventional trials, observational trials and expanded access), by therapeutic application (oncology, cardiology and other areas) and by deployment mode (cloud-based decentralized clinical trial (DCT) platforms and on-premises solutions). End users include pharmaceutical and biotechnology companies, contract research organizations (CROs) and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the rest of Europe, China, Japan, India, South Korea and the rest of Asia-Pacific.
The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies. It offers company profiles covering financials, product portfolios and recent developments.
Report Includes
- An overview of the global markets for decentralized clinical trials (DCT)
- An analysis of the global market trends with market revenue data from 2022- 2025, and projected CAGRs through 2030
- Estimates of the size and revenue prospects of the global market, along with a market share analysis by study design, therapeutic application, deployment mode, end user, and region
- Facts and figures pertaining to the market dynamics, technical advances, regulations, impact of macroeconomic factors, and R&D activities
- Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Company profiles
Executive Summary
Summary:
The report provides an overview of the global decentralized clinical trials (DCT) market and analyzes market trends. It includes global revenue ($ Million) for the base year data of 2024 and for the forecast period 2025 through 2030.
This report analyzes the trends in the global market for decentralized clinical trials. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period of 2025 through 2030. The market is segmented by study design (interventional trials, observational trials and expanded access), by therapeutic application (oncology, cardiology and other areas) and by deployment mode (cloud-based decentralized clinical trial (DCT) platforms and on-premises solutions). End users include pharmaceutical and biotechnology companies, contract research organizations (CROs) and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the rest of Europe, China, Japan, India, South Korea and the rest of Asia-Pacific.
The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies. It offers company profiles covering financials, product portfolios and recent developments.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Analysis
Emerging Technologies
Conclusion
Chapter 2 Market Overview
Current Market Overview
Macroeconomic Factors Analysis
Demographic Factors
Geopolitical Factors
Impact of the U.S. Tariffs
Porter's Five Forces Analysis
Potential for New Entrants: Moderate
Bargaining Power of Suppliers: Moderate
Bargaining Power of Buyers: Moderate to High
Threat of Substitute Products or Services: Low to Moderate
Industry Competition: High
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Demand for Improved Patient Access and Trial Diversity
Favorable Regulatory Support for Decentralized Clinical Trials
Technological Proliferation and Digital Infrastructure
Market Restraints
Data Integrity and Security Concerns
Operational and Logistical Complexities
Market Opportunities
Integration of Artificial Intelligence and Wearable Technologies
Extending Clinical Research Reach to Underserved and Remote Areas
Chapter 4 Regulatory Landscape
Overview
U.S.
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Developments
Key Takeaways
Next-Generation Digital Trial Platforms and Integrated Ecosystems
Wearables, Remote Monitoring and Digital Biomarkers
Automation, AI and Predictive Trial Management
Digital Patient and Investigator Workflow Optimization
Chapter 6 Market Segmentation Analysis
Overview
Segmentation Breakdown
Market Analysis by Study Design
Key Takeaways
Interventional Trials
Observational Trials
Expanded Access
Market Analysis by Therapeutic Application
Key Takeaways
Oncology
Cardiology
Others
Market Analysis by Deployment Mode
Key Takeaways
Cloud-Based DCT Platforms
On-Premises Solutions
Market Analysis by End User
Key Takeaways
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Other End Users
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Analysis
Strategic Initiatives
Mergers and Acquisitions
Collaborations
Chapter 8 Appendix
Research Methodology
Sources
Abbreviations
Company Profiles
CLARIO
FORTREA
ICON PLC
LABCORP
MEDABLE INC.
MEDIDATA
OBVIO HEALTH USA INC.
PAREXEL INTERNATIONAL (MA) CORP.
THERMO FISHER SCIENTIFIC INC.
VEEVA SYSTEMS INC.
List of Tables
Summary Table : Global Market for Decentralized Clinical Trials, by Region, Through 2030
Table 1 : Global Market for Decentralized Clinical Trials, by Study Design, Through 2030
Table 2 : Global Market for Interventional Decentralized Clinical Trials, by Region, Through 2030
Table 3 : Global Market for Observational Decentralized Clinical Trials, by Region, Through 2030
Table 4 : Global Market for Expanded Access Decentralized Clinical Trials, by Region, Through 2030
Table 5 : Global Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
Table 6 : Global Market for Oncology in Decentralized Clinical Trials, by Region, Through 2030
Table 7 : Global Market for Cardiology in Decentralized Clinical Trials, by Region, Through 2030
Table 8 : Global Market for Other Therapeutic Applications in Decentralized Clinical Trials, by Region, Through 2030
Table 9 : Global Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
Table 10 : Global Market for Cloud-Based DCT Platforms in Decentralized Clinical Trials, by Region, Through 2030
Table 11 : Global Market for On-Premises Solutions in Decentralized Clinical Trials, by Region, Through 2030
Table 12 : Global Market for Decentralized Clinical Trials, by End User, Through 2030
Table 13 : Global Market for Pharmaceutical and Biotechnology Companies in Decentralized Clinical Trials, by Region, Through 2030
Table 14 : Global Market for CROs in Decentralized Clinical Trials, by Region, Through 2030
Table 15 : Global Market for Other End Users in Decentralized Clinical Trials, by Region, Through 2030
Table 16 : Global Market for Decentralized Clinical Trials, by Region, Through 2030
Table 17 : North American Market for Decentralized Clinical Trials, by Study Design, Through 2030
Table 18 : North American Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
Table 19 : North American Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
Table 20 : North American Market for Decentralized Clinical Trials, by End User, Through 2030
Table 21 : European Market for Decentralized Clinical Trials, by Study Design, Through 2030
Table 22 : European Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
Table 23 : European Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
Table 24 : European Market for Decentralized Clinical Trials, by End User, Through 2030
Table 25 : Asia-Pacific Market for Decentralized Clinical Trials, by Study Design, Through 2030
Table 26 : Asia-Pacific Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
Table 27 : Asia-Pacific Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
Table 28 : Asia-Pacific Market for Decentralized Clinical Trials, by End User, Through 2030
Table 29 : RoW Market for Decentralized Clinical Trials, by Study Design, Through 2030
Table 30 : RoW Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
Table 31 : RoW Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
Table 32 : RoW Market for Decentralized Clinical Trials, by End User, Through 2030
Table 33 : Global Ranking of Companies in the Market for Decentralized Clinical Trials, 2024
Table 34 : Mergers and Acquisitions in the Decentralized Clinical Trials Industry, 2025
Table 35 : Collaborations in the Decentralized Clinical Trials Industry, 2023-2025
Table 36 : Information Sources Used for this Report
Table 37 : Abbreviations Used in this Report
Table 38 : Clario: Company Snapshot
Table 39 : Clario: Product Portfolio
Table 40 : Clario: News/Key Developments, 2023-2025
Table 41 : Fortrea: Company Snapshot
Table 42 : Fortrea: Financial Performance, FY 2023 and 2024
Table 43 : Fortrea: Product Portfolio
Table 44 : Fortrea: News/Key Developments, 2023-2025
Table 45 : ICON plc: Company Snapshot
Table 46 : ICON plc: Financial Performance, FY 2023 and 2024
Table 47 : ICON plc: Product Portfolio
Table 48 : ICON plc: News/Key Developments, 2023-2025
Table 49 : Labcorp: Company Snapshot
Table 50 : Labcorp: Financial Performance, FY 2023 and 2024
Table 51 : Labcorp: Product Portfolio
Table 52 : Labcorp: News/Key Developments, 2022-2025
Table 53 : Medable Inc.: Company Snapshot
Table 54 : Medable Inc.: Product Portfolio
Table 55 : Medable Inc.: News/Key Developments, 2023-2025
Table 56 : Medidata: Company Snapshot
Table 57 : Medidata: Product Portfolio
Table 58 : Medidata: News/Key Developments, 2023-2025
Table 59 : Obvio Health USA Inc.: Company Snapshot
Table 60 : Obvio Health USA Inc.: Product Portfolio
Table 61 : Obvio Health USA Inc.: News/Key Developments, 2023-2025
Table 62 : Parexel International (MA) Corp.: Company Snapshot
Table 63 : Parexel International (MA) Corp.: Product Portfolio
Table 64 : Parexel International (MA) Corp.: News/Key Developments, 2024-2025
Table 65 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 66 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 67 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 68 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023-2025
Table 69 : Veeva Systems Inc.: Company Snapshot
Table 70 : Veeva Systems Inc.: Financial Performance, FY 2023 and 2024
Table 71 : Veeva Systems Inc.: Product Portfolio
Table 72 : Veeva Systems Inc.: News/Key Developments, 2025
List of Figures
Summary Figure : Global Market Shares for Decentralized Clinical Trials, by Region, 2024
Figure 1 : Porter's Five Forces Analysis of the Market for Decentralized Clinical Trials
Figure 2 : Snapshot of the Market Dynamics for Decentralized Clinical Trials
Figure 3 : Global Market Shares for Decentralized Clinical Trials, by Study Design, 2024
Figure 4 : Global Market Shares for Decentralized Clinical Trials, by Therapeutic Application, 2024
Figure 5 : Global Market Shares for Decentralized Clinical Trials, by Deployment Mode, 2024
Figure 6 : Global Market Shares for Decentralized Clinical Trials, by End User, 2024
Figure 7 : Global Market Shares for Decentralized Clinical Trials, by Region, 2024
Figure 8 : ICON plc: Revenue Shares, by Country/Region, FY 2024
Figure 9 : Labcorp: Revenue Shares, by Business Unit, FY 2024
Figure 10 : Labcorp: Revenue Shares, by Country/Region, FY 2024
Figure 11 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 12 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 13 : Veeva Systems Inc.: Revenue Shares, by Country/Region, FY 2024
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security